NCT06768307 2025-01-10
Assessment of Adebelizumab Combined with Chemotherapy in Concurrent Radiotherapy Versus Sequential Radiotherapy As First-Line Treatment for Extensive-Stage Small Cell Lung Cancer
Peking University Cancer Hospital & Institute
Phase 2 Not yet recruiting